| Megan Lynn Jones, MS, CF-SLP | |
|
700 Marvel Rd, Milford, DE 19963-1740 | |
| (302) 422-3303 | |
| Not Available |
| Full Name | Megan Lynn Jones |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 700 Marvel Rd, Milford, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285364851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Lynn Jones, MS, CF-SLP 1724 Mcginnis Pond Rd, Magnolia, DE 19962-1555 Ph: (302) 242-6602 | Megan Lynn Jones, MS, CF-SLP 700 Marvel Rd, Milford, DE 19963-1740 Ph: (302) 422-3303 |
News Archive
The licence grants Zentaris exclusive worldwide rights for the development, manufacture and marketing of disorazoles, a novel class of natural products with strong anti-cancer potential discovered by GBF researchers.
People with Alzheimer's disease have fat deposits in the brain. For the first time since the disease was described 109 years ago, researchers affiliated with the University of Montreal Hospital Research Centre (CRCHUM) have discovered accumulations of fat droplets in the brain of patients who died from the disease and have identified the nature of the fat.
When Miriam McDonald decided she wanted to have another baby at age 44, her doctor told her she had a better chance of winning the lottery. So when she got pregnant right away, she and her husband were thrilled. But within three days of giving birth to their son, in September 2019, everything shifted.
Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident.
› Verified 4 days ago
Karen Sattem, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17125 Deer Run, Milford, DE 19963 Phone: 302-894-4021 | |
Heather Motter, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 906 Lakeview Ave, Milford, DE 19963 Phone: 302-422-1600 | |
Brie Wyatt, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Delaware Veterans Blvd, Milford, DE 19963 Phone: 302-424-6025 | |
Marissa Plummer, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 906 Lakeview Ave, Milford, DE 19963 Phone: 302-422-1600 | |
Lisa Gatts, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Wellness Way, Milford, DE 19963 Phone: 302-503-7775 | |
Jennifer Renee King, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4436 S Bowers Rd, Milford, DE 19963 Phone: 717-314-9124 |